TickerFacts.

A business in context

MAZE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-24 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-15 · 0001193125-26-424067 · Items 1.01,3.02,9.01

  2. 4 · Ownership change

    Report date 2026-10-01 · 0002050172-26-000038

  3. 4 · Ownership change

    Report date 2026-10-01 · 0001676170-26-000024

  4. 4 · Ownership change

    Report date 2026-09-29 · 0002050167-26-000030

  5. 4 · Ownership change

    Report date 2026-09-04 · 0002050172-26-000036

  6. 4 · Ownership change

    Report date 2026-09-02 · 0002050172-26-000034

  7. 4 · Ownership change

    Report date 2026-09-02 · 0002050167-26-000027

  8. 4 · Ownership change

    Report date 2026-09-02 · 0001782758-26-000008

  9. 4 · Ownership change

    Report date 2026-09-02 · 0001676170-26-000022

  10. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-354092 · Items 5.02,7.01,9.01

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-344903

  12. 8-K · Current report

    Report date 2026-08-11 · 0001193125-26-344878 · Items 2.02,9.01

  13. 8-K · Current report

    Report date 2026-06-08 · 0001193125-26-265858 · Items 5.07

  14. 8-K · Current report

    Report date 2026-05-18 · 0001193125-26-237199 · Items 5.02

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-219430

  16. 8-K · Current report

    Report date 2026-05-12 · 0001193125-26-219398 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-08 · 0001140361-26-017463

  18. 8-K · Current report

    Report date 2026-04-21 · 0001193125-26-170701 · Items 8.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-122778

  20. 8-K · Current report

    Report date 2026-03-24 · 0001193125-26-122774 · Items 2.02,5.02,7.01,9.01

  21. 8-K · Current report

    Report date 2026-02-02 · 0001193125-26-037747 · Items 1.01,1.02,2.03

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269689

  23. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269624 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-10-06 · 0001193125-25-230926 · Items 5.02

  25. 8-K · Current report

    Report date 2025-09-10 · 0001193125-25-200760 · Items 1.01,3.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-09-02 · 0001193125-25-193353 · Items 5.02

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-107306

  28. 8-K · Current report

    Report date 2025-08-12 · 0000950170-25-107299 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-071375

  30. 8-K · Current report

    Report date 2025-05-14 · 0000950170-25-071357 · Items 2.02,9.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-047208

  32. 8-K · Current report

    Report date 2025-03-31 · 0000950170-25-047207 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 34 transaction rows34SGrant / award: 2 transaction rows2AExercise / conversion: 20 transaction rows20MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

56 matching transaction rows. Showing 51 to 56.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-01
2026-07-02
Coloma Jason V
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1597.030.44
2026-07-01
2026-07-02
Coloma Jason V
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2593.029.98
2026-07-01
2026-07-02
Coloma Jason V
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock30311.029.95
2026-06-29
2026-07-01
Dandekar Atul
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7500.028.02
2026-06-29
2026-07-01
Dandekar Atul
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock7500.010.42
2026-06-29
2026-07-01
Dandekar Atul
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
7500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001842295Maze Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$167.50M$179.91M

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗